Renewable sites › GlaxoSmithKline Wind Project (Turbine 4)
GlaxoSmithKline Wind Project (Turbine 4)
GlaxoSmithKline Wind Project (Turbine 4) is an operational 2.5 MW onshore wind farm in North Ayrshire, generating since 1 June 2014. Planning permission was granted on 19 June 2013, 7 months after submission. Operator of record: GlaxoSmithKline.
Planning and build timeline
| Application submitted | 13 November 2012 |
| Permission granted | 19 June 2013 7 months after submission |
| Operational | 1 June 2014 11 months after consent |
Screening a site of your own?
North Ayrshire approves 78% of onshore wind schemes. Redline puts that number, and everything else the record holds, against your own boundary: the authority’s actual approval rate and decision times, every designation inside the red line, agricultural grade, 1 m LIDAR earthworks, how contested the grid is, and yield with a P90 — before you spend on a consultant.
Arrives prefilled with GlaxoSmithKline Wind Project (Turbine 4)’s recorded coordinate — swap in your own postcode or coordinates.
North Ayrshire’s record on onshore wind
North Ayrshire has decided 18 onshore wind schemes and approved 78%, taking a median of 8.5 months. See every onshore wind scheme decision in North Ayrshire →
Other built sites within 15 km
| Site | MW | Distance |
|---|---|---|
Solar Photovoltaics · Under Construction | 19.9 | 0.7 km |
Anaerobic Digestion · Operational | 1 | 0.8 km |
Wind Onshore · Under Construction | 3 | 1 km |
Wind Onshore · Operational | 7.5 | 1.1 km |
EfW Incineration · Under Construction | 17 | 1.4 km |
Biomass (dedicated) · Operational | 26 | 2 km |
Solar Photovoltaics · Under Construction | 5 | 2.1 km |
Solar Photovoltaics · Under Construction | 7.5 | 4.2 km |
How big is GlaxoSmithKline Wind Project (Turbine 4)?
GlaxoSmithKline Wind Project (Turbine 4) has a recorded installed capacity of 2.5 MW. That figure is the capacity registered in REPD, which is the scheme as consented — the metered output of a site can differ.
Who operates GlaxoSmithKline Wind Project (Turbine 4)?
REPD records the operator as GlaxoSmithKline. Ownership of built renewable assets changes hands regularly and REPD is published quarterly, so treat this as the operator of record rather than confirmation of who owns it today.
When was GlaxoSmithKline Wind Project (Turbine 4) approved and built?
The application was submitted on 13 November 2012. Permission was granted on 19 June 2013, 7 months later. The site became operational on 1 June 2014, 11 months after consent.
Source: Renewable Energy Planning Database (REPD), Department for Energy Security and Net Zero, Open Government Licence v3.0, plus planning designation boundaries from planning.data.gov.uk (England only). REPD is published quarterly and covers schemes of roughly 150 kW and above. Capacity is the installed capacity on record, not metered generation. Operator is the operator of record at the last extract, not confirmation of present ownership. Reference 4370.
Novarly Parcel · official public data, read properly · parcel.novarly.com
All sites · Screen your own site · Planning by council · Coal mining search by postcode